QQQ   431.85 (+0.18%)
AAPL   169.32 (-1.95%)
MSFT   416.93 (+0.80%)
META   501.56 (+0.27%)
GOOGL   154.34 (-0.34%)
AMZN   184.47 (+0.46%)
TSLA   157.93 (-2.20%)
NVDA   874.72 (+1.71%)
AMD   164.24 (+2.45%)
NIO   3.83 (-1.54%)
BABA   69.51 (-1.57%)
T   15.99 (-1.54%)
F   12.09 (-1.14%)
MU   120.96 (-0.34%)
GE   154.35 (+0.42%)
CGC   7.04 (+0.86%)
DIS   114.14 (+1.05%)
AMC   2.66 (+7.69%)
PFE   25.83 (-0.31%)
PYPL   63.84 (+0.52%)
XOM   118.83 (-0.71%)
QQQ   431.85 (+0.18%)
AAPL   169.32 (-1.95%)
MSFT   416.93 (+0.80%)
META   501.56 (+0.27%)
GOOGL   154.34 (-0.34%)
AMZN   184.47 (+0.46%)
TSLA   157.93 (-2.20%)
NVDA   874.72 (+1.71%)
AMD   164.24 (+2.45%)
NIO   3.83 (-1.54%)
BABA   69.51 (-1.57%)
T   15.99 (-1.54%)
F   12.09 (-1.14%)
MU   120.96 (-0.34%)
GE   154.35 (+0.42%)
CGC   7.04 (+0.86%)
DIS   114.14 (+1.05%)
AMC   2.66 (+7.69%)
PFE   25.83 (-0.31%)
PYPL   63.84 (+0.52%)
XOM   118.83 (-0.71%)
QQQ   431.85 (+0.18%)
AAPL   169.32 (-1.95%)
MSFT   416.93 (+0.80%)
META   501.56 (+0.27%)
GOOGL   154.34 (-0.34%)
AMZN   184.47 (+0.46%)
TSLA   157.93 (-2.20%)
NVDA   874.72 (+1.71%)
AMD   164.24 (+2.45%)
NIO   3.83 (-1.54%)
BABA   69.51 (-1.57%)
T   15.99 (-1.54%)
F   12.09 (-1.14%)
MU   120.96 (-0.34%)
GE   154.35 (+0.42%)
CGC   7.04 (+0.86%)
DIS   114.14 (+1.05%)
AMC   2.66 (+7.69%)
PFE   25.83 (-0.31%)
PYPL   63.84 (+0.52%)
XOM   118.83 (-0.71%)
QQQ   431.85 (+0.18%)
AAPL   169.32 (-1.95%)
MSFT   416.93 (+0.80%)
META   501.56 (+0.27%)
GOOGL   154.34 (-0.34%)
AMZN   184.47 (+0.46%)
TSLA   157.93 (-2.20%)
NVDA   874.72 (+1.71%)
AMD   164.24 (+2.45%)
NIO   3.83 (-1.54%)
BABA   69.51 (-1.57%)
T   15.99 (-1.54%)
F   12.09 (-1.14%)
MU   120.96 (-0.34%)
GE   154.35 (+0.42%)
CGC   7.04 (+0.86%)
DIS   114.14 (+1.05%)
AMC   2.66 (+7.69%)
PFE   25.83 (-0.31%)
PYPL   63.84 (+0.52%)
XOM   118.83 (-0.71%)

Silence Therapeutics (SLN) SEC Filings & 10K Form

$21.70
+1.04 (+5.03%)
(As of 11:14 AM ET)

Recent Silence Therapeutics SEC Filings

DateFilerForm TypeView
03/13/2024
7:52 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/13/2024
6:10 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
7:12 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
8:54 AM
Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
02/14/2024
7:55 AM
Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
02/12/2024
5:15 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
02/09/2024
4:05 PM
Artal International S.C.A. (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
12/01/2023
6:00 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2023
6:00 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/01/2023
3:12 PM
Artal International S.C.A. (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G
08/16/2023
6:00 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2023
3:31 PM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/11/2023
6:00 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2023
6:30 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/04/2023
6:41 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/01/2023
6:31 AM
Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SLN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners